Discovery of N-substituted-2-((arylethyl)amino)-2-(2-methoxyphenyl) acetamides: A novel family of antiplatelet agents

IF 6.9 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Biomedicine & Pharmacotherapy Pub Date : 2025-03-17 DOI:10.1016/j.biopha.2025.117971
Lyanne Rodríguez , Carlos Rodríguez , Jhonny Azuaje , Rubén Prieto-Díaz , Antón L. Martínez , María I. Loza , José Brea , David Reza , Eddy Sotelo , Eduardo Fuentes
{"title":"Discovery of N-substituted-2-((arylethyl)amino)-2-(2-methoxyphenyl) acetamides: A novel family of antiplatelet agents","authors":"Lyanne Rodríguez ,&nbsp;Carlos Rodríguez ,&nbsp;Jhonny Azuaje ,&nbsp;Rubén Prieto-Díaz ,&nbsp;Antón L. Martínez ,&nbsp;María I. Loza ,&nbsp;José Brea ,&nbsp;David Reza ,&nbsp;Eddy Sotelo ,&nbsp;Eduardo Fuentes","doi":"10.1016/j.biopha.2025.117971","DOIUrl":null,"url":null,"abstract":"<div><div>The development of new antiplatelet agents is essential due to the limitations of existing therapies and the high prevalence of thrombotic disorders. As part of a project aimed at harnessing multicomponent-assisted synthetic strategies for drug discovery, we identified a novel class of potent antiplatelet compounds. Herein we report the design, synthesis, and pharmacological evaluation of a new series of N-substituted-2-((arylethyl)amino)-2-(2-methoxyphenyl)acetamides, along with structure-activity relationship analysis and a preliminary investigation of their mechanism of action. The most active compounds, 7d, 9e, and 6f, exhibited IC₅₀ values of 0.92 ± 0.24, 0.59 ± 0.10, and 0.39 ± 0.07 µM, respectively, in serotonin (30 µM) plus collagen (1 µg/mL)-induced platelet aggregation assays, outperforming sarpogrelate (IC₅₀ 5.41 ± 1.25). Functional and binding studies confirmed that these compounds act as low-affinity, weak partial agonists at 5-HT<sub>2A</sub>, suggesting their antiplatelet effects arise from serotonin-dependent pathways rather than direct 5-HT<sub>2A</sub> receptor antagonism. Additional experiments confirmed that the selected compounds are non-cytotoxic and significantly suppress P-selectin expression and CD63 secretion, demonstrating inhibition of both early and late stages of platelet activation. These findings introduce a new mechanistic approach to platelet inhibition, expanding the chemical space for antiplatelet drug development. Further studies should focus on molecular target identification and combination therapy potential for thrombosis treatment.</div></div>","PeriodicalId":8966,"journal":{"name":"Biomedicine & Pharmacotherapy","volume":"186 ","pages":"Article 117971"},"PeriodicalIF":6.9000,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedicine & Pharmacotherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0753332225001659","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

The development of new antiplatelet agents is essential due to the limitations of existing therapies and the high prevalence of thrombotic disorders. As part of a project aimed at harnessing multicomponent-assisted synthetic strategies for drug discovery, we identified a novel class of potent antiplatelet compounds. Herein we report the design, synthesis, and pharmacological evaluation of a new series of N-substituted-2-((arylethyl)amino)-2-(2-methoxyphenyl)acetamides, along with structure-activity relationship analysis and a preliminary investigation of their mechanism of action. The most active compounds, 7d, 9e, and 6f, exhibited IC₅₀ values of 0.92 ± 0.24, 0.59 ± 0.10, and 0.39 ± 0.07 µM, respectively, in serotonin (30 µM) plus collagen (1 µg/mL)-induced platelet aggregation assays, outperforming sarpogrelate (IC₅₀ 5.41 ± 1.25). Functional and binding studies confirmed that these compounds act as low-affinity, weak partial agonists at 5-HT2A, suggesting their antiplatelet effects arise from serotonin-dependent pathways rather than direct 5-HT2A receptor antagonism. Additional experiments confirmed that the selected compounds are non-cytotoxic and significantly suppress P-selectin expression and CD63 secretion, demonstrating inhibition of both early and late stages of platelet activation. These findings introduce a new mechanistic approach to platelet inhibition, expanding the chemical space for antiplatelet drug development. Further studies should focus on molecular target identification and combination therapy potential for thrombosis treatment.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.90
自引率
2.70%
发文量
1621
审稿时长
48 days
期刊介绍: Biomedicine & Pharmacotherapy stands as a multidisciplinary journal, presenting a spectrum of original research reports, reviews, and communications in the realms of clinical and basic medicine, as well as pharmacology. The journal spans various fields, including Cancer, Nutriceutics, Neurodegenerative, Cardiac, and Infectious Diseases.
期刊最新文献
A phthalimide-triazole derivative obtained by click chemistry exhibits trypanocidal activity, induces autophagy and ameliorates Trypanosoma cruzi infection Discovery of N-substituted-2-((arylethyl)amino)-2-(2-methoxyphenyl) acetamides: A novel family of antiplatelet agents Anti-inflammatory, antioxidant, and acute toxicity of Brugmansia arborea extracts from wild plants and shoots obtained by indirect organogenesis. A thermographic assay to anti-inflammatory evaluation Two concurrent mechanisms are responsible for the INa increase produced by dapagliflozin and empagliflozin in healthy and heart failure cardiomyocytes Discussion of the material basis for prevention and treatment of pulmonary fibrosis using naturally medicinal and edible homologous herbs based on the dynamic process of Nrf2, NF-κB and TGF-β in PF
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1